Name: ABSA’s 1st Biosecurity Symposium
Start: 2021-04-20T00:00:00-05:00
End: 2021-04-23T23:59:59-05:00
Location: Renaissance Depot Hotel

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

CRDF Global Selected to Support Biological Threat Reduction Program Contracts

by Global Biodefense Staff October 19, 2020, 4:06 pm
MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2

by Global Biodefense Staff October 15, 2020, 10:46 am
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

by Global Biodefense Staff October 15, 2020, 7:18 am
DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal

by Global Biodefense Staff October 15, 2020, 5:04 am
NIH Funds a $9.3M Center for Precision Animal Modeling at UAB

by Global Biodefense Staff October 9, 2020, 12:09 pm
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV

by Global Biodefense Staff October 8, 2020, 11:28 am
Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant

by Global Biodefense Staff October 7, 2020, 9:48 am
NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

by Global Biodefense Staff October 7, 2020, 9:25 am
Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development

by Global Biodefense Staff September 28, 2020, 10:13 am
National COVID-19 Vaccination Strategy: DoD Awards $125M to Goldbelt Security

by Global Biodefense Staff September 4, 2020, 9:09 am
Newsletter

Global Biodefense News

First Name

Last Name

Organization Type

Email address:

Don't worry, we don't spam
USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

by Global Biodefense Staff September 2, 2020, 2:12 pm
NIAID Establishes New Global Network to Focus on Spillover Potential of Emerging Diseases

by Global Biodefense Staff August 27, 2020, 11:55 am
DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

by Global Biodefense Staff July 8, 2020, 2:06 pm
This Atomically Thin Detector Could Become a Biotech Breakthrough

by Global Biodefense Staff May 25, 2020, 8:29 am

Congratulations. You've reached the end of the internet.

Awards

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Virginia Tech Awarded USDA Grant to Study Survival of SARS-CoV-2 on Food Supply Chain Surfaces

InBios Awarded $12.7M to Boost Production of Two COVID-19 Diagnostics

BARDA Awards Medical Countermeasures Clinical Studies Network Contracts

CRDF Global Selected to Support Biological Threat Reduction Program Contracts

MIS-C Detection: BARDA Invests in Rapid Diagnostic for Pediatric Complication of SARS-CoV-2

U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva

DoD Expands U.S. Domestic Diagnostics Capacity with $481M Cue Health Deal

NIH Funds a $9.3M Center for Precision Animal Modeling at UAB

BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV

Renowned Tick Immunobiologist to Develop Lyme Disease Vaccine Under New $3.5M Federal Grant

NIH RADx Initiative Advances Six New COVID-19 Testing Technologies

Basilea Awarded Additional Funding from U.S. Medical Countermeasure Program for Ceftobiprole Development

National COVID-19 Vaccination Strategy: DoD Awards $125M to Goldbelt Security

USAMMDA to Manage Tier 1 Acquisition Program for Three COVID-19 Countermeasures

NIAID Establishes New Global Network to Focus on Spillover Potential of Emerging Diseases

DoD Awards $450M Contract for Coronavirus Antibody Manufacturing

This Atomically Thin Detector Could Become a Biotech Breakthrough

Biodefense Headlines – 21 January 2021

First Cases of B.1.1.7 Variant COVID-19 Detected in Washington State

The Response Measures Database: Central Archive of COVID-19 Interventions

EU Initiative on Health Security Work Programme 2021

Rapid Identification of Ricin in Serum Samples Using LC–MS/MS

Dr. Fauci Makes First Appearance at Biden White House Press Briefing – Transcript

ASM Expresses Support for the Global Health Security Act of 2021

How and When Will Lower-Income Countries Gain Access to COVID-19 Vaccines?

OHDSI Awarded $10M FDA Contract to Monitor Safety and Effectiveness of Vaccines, Biologics

Neutralizing Norovirus: NIAID Monoclonal Antibodies Licensing Opportunity

NIAID Looks Ahead to Pan-Coronavirus Vaccine Candidates

DRIVE ReDIRECT: Program Seeks to Develop Countermeasures Against Chemical Threats

Emerging Infections Network – Managing Travelers Who Acquire Disease Abroad

Upcoming Events

Application Deadline: Expanding Existing Research Grants, CRADAs for Novel Coronavirus Response

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 2

Systematizing the One Health Approach in Preparedness and Response Efforts for Infectious Disease Outbreaks

Envisioning a Transformed Clinical Trials Enterprise for 2030 – Session 3

ABSA’s 1st Biosecurity Symposium

Latest stories

Latest Articles